|Videos|June 15, 2022
Urology Times 50 Innovations Series: Multichannel urodynamics
Author(s)Urology Times staff
“What made [multichannel urodynamics] so important is you're able to diagnose things much better; you're able to have a much better understanding of what's actually going on,” says Howard B. Goldman, MD, FACS.
Advertisement
Urology Times® is celebrating its 50th anniversary in 2022. To mark the occasion, we are highlighting 50 of the top innovations and developments that have transformed the field of urology over the past 50 years. In this installment, Howard Goldman, MD, discusses the development of multichannel urodynamics testing. Goldman is a professor of urology and vice chair of the Glickman Urologic Institute at Cleveland Clinic.
Advertisement
Related to this article
The completion of the first procedure marks the beginning of a controlled US commercial release.
Butterfly Medical has also submitted a premarket approval application to the FDA.
Rezūm improved symptoms and quality of life at 1 year vs combination pharmacotherapy in sexually active men with BPO while preserving sexual function.
Advertisement
Advertisement
Trending on Urology Times
1
How PSMA-PET shapes staging and recurrence workup in prostate cancer
2
ESMO 2026: Key presentations across genitourinary oncology
3
Engy Habashy, MD, on the role of androgens in GSM management
4
European Commission approves perioperative pembrolizumab plus enfortumab vedotin for MIBC
5